Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29180304 | 1.00 | NPSR1 (0.57) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL14843402 | 0.79 | HSD17B10 (0.55) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL1233845 | 0.79 | HSD17B10 (0.55) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL3876229 | 0.79 | NPSR1 (0.55) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL30469025 | 0.79 | NPSR1 (0.41) | NPSR1HSD17B10TSHRHPGDGAA | |
| SCHEMBL5431043 | 0.79 | NPSR1 (0.55) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL18258603 | 0.79 | NPSR1 (0.55) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL18258629 | 0.76 | NPSR1 (0.52) | NPSR1HSD17B10PPARGTSHRHPGD | |
| SCHEMBL5512388 | 0.76 | NPSR1 (0.52) | NPSR1HSD17B10PPARGHPGDMAPT | |
| SCHEMBL14843770 | 0.76 | HSD17B10 (0.52) | NPSR1HSD17B10PPARGHPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117567344-A | Environment-friendly preparation method of compound containing chiral pyrrole skeleton | 广西中医药大学 | 2024-02-20 | — | — | CN | disclosed |
| US-20110065794-A1 | Wrinkle-preventing and improving composition | SHISEIDO COMPANY, LTD. (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20100168468-A1 | WRINKLE-PREVENTING AND IMPROVING COMPOSITION | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-07-01 | — | — | US | disclosed |
| EP-1908454-A1 | WRINKLE-PREVENTIVE/AMELIORATING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2008-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168468-A1 | WRINKLE-PREVENTING AND IMPROVING COMPOSITION | COL1A1, COL2A1, COL14A1 | NPSR1 2902/4885HSD17B10 632/4885PPARG 62/4885 |
| US-20110065794-A1 | Wrinkle-preventing and improving composition | COL1A1, COL2A1, COL14A1 | NPSR1 2902/4885HSD17B10 632/4885PPARG 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.